alphaveALKEM₹5,111.00

Alkem Laboratories Ltd.

₹ CrorePeersMANKIND TORNTPHARM IPCALAB LUPIN FORTIS AUROPHARMA LAURUSLABS BIOCONMcap ₹61,102 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	2,161.5	2,063.9	2,695.0	2,695.0
+ Capital Work-in-Progress	148.4	476.6	137.9	137.9
+ Goodwill	416.7	423.1	523.6	523.6
+ Other Intangibles	294.6	365.3	652.4	652.4
+ Intangibles under Development	10.2	71.5	143.9	143.9
+ Non-current Investments	334.8	943.2	1,131.5	1,131.5
+ Other Non-current Financial Assets	120.2	475.4	1,215.7	1,215.7
Non-current Financial Assets	455.0	1,418.6	2,347.2	2,347.2
+ Deferred Tax Assets	1,514.8	1,738.3	1,819.4	1,819.4
+ Other Non-current Assets	162.1	188.1	343.0	343.0
Total Non-current Assets	5,163.3	6,745.3	8,662.5	8,662.5
Current Assets
+ Inventories	2,661.2	2,922.4	3,333.2	3,333.2
+ Current Investments	149.0	902.3	737.3	737.3
+ Trade Receivables	2,252.8	2,466.3	2,979.1	2,979.1
+ Cash & Cash Equivalents	455.1	304.1	247.9	247.9
+ Other Bank Balances	1,124.3	1,258.9	1,485.0	1,485.0
+ Short-term Loans	9.1	9.0	6.6	6.6
+ Other Current Financial Assets	2,930.2	2,115.5	2,522.5	2,522.5
Current Financial Assets	6,920.4	7,056.1	7,978.5	7,978.5
+ Other Current Assets	830.0	832.7	898.8	898.8
Total Current Assets	10,411.6	10,811.2	12,210.5	12,210.5
Total Assets	15,574.9	17,691.1	20,873.0	20,873.0
Equity
+ Equity Share Capital	23.9	23.9	23.9	23.9
+ Other Equity / Reserves	10,288.2	11,961.0	13,796.2	13,796.2
Equity — Owners of Parent	10,312.1	11,984.9	13,820.1	13,820.1
+ Minority Interest	402.3	448.8	528.8	528.8
Total Equity	10,714.4	12,433.6	14,348.9	14,348.9
Liabilities
+ Borrowings — Non-current	40.0	310.9	492.5	492.5
+ Other Non-current Financial Liab	500.3	621.4	784.5	784.5
Non-current Financial Liabilities	540.3	932.3	1,276.9	1,276.9
+ Provisions — Non-current	299.9	338.2	431.2	431.2
+ Deferred Tax Liabilities	—	0.0	15.1	15.1
+ Other Non-current Liabilities	25.8	22.0	18.1	18.1
Non-current Liabilities	866.0	1,292.5	1,741.3	1,741.3
+ Borrowings — Current	1,174.0	751.9	1,131.1	1,131.1
+ Trade Payables	1,748.1	1,839.4	2,244.2	2,244.2
+ Other Current Financial Liab	661.0	841.6	821.1	821.1
Current Financial Liabilities	3,583.0	3,432.8	4,196.3	4,196.3
+ Provisions — Current	126.9	159.1	200.7	200.7
+ Current Tax Liabilities	55.0	61.1	66.5	66.5
+ Other Current Liabilities	229.7	305.7	319.2	319.2
Current Liabilities	3,994.6	3,958.7	4,782.7	4,782.7
Total Liabilities	4,860.5	5,257.5	6,524.0	6,524.0
Total Equity & Liabilities	15,574.9	17,691.1	20,873.0	20,873.0
Assets — additional as-filed lines
+ Non-current Assets Held for Sale	0.0	134.6	—	—
Liabilities — additional as-filed lines
+ Liabilities of Disposal Group Held for Sale	0.0	6.3	—	—
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	88.0	197.1	197.1
+ Dues to Other Creditors — Current	—	1,751.4	2,047.0	2,047.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.